UiPath (PATH) declined 1.43% to $13.06 in the latest session, underperforming the S&P 500's 1.11% loss. Despite a 6.89% monthly drop, the company maintains a Zacks Rank #2 (Buy) rating with positive earnings revisions. Analysts project Q earnings of $0.19 per share (+18.75% YoY) and full-year revenue of $1.79 billion (+11.25% YoY). The stock trades at a Forward P/E of 16.7, below its industry average of 20.8.

UiPath (PATH) has gained 33% over six months, driven by expanding AI capabilities through its Maestro platform and improving profitability. Q2 revenues rose 13% to $410M with ARR climbing 12% to $1.94B. Trading at a forward P/E of 15.29 versus the industry average of 30.92, PATH appears undervalued. However, intensifying competition and uncertain enterprise spending pose risks to growth.

The article compares C3.ai and UiPath as investments in the agentic AI automation space. UiPath is recommended as the better buy due to its profitability, positive free cash flow, and consistent growth trajectory. C3.ai, while showing recent improvements like positive free cash flow and 73% quarter-over-quarter booking growth, remains unprofitable with substantial net losses and is still in early restructuring stages under CEO Thomas Siebel.

UiPath (PATH) is a trending stock with a Zacks Rank #2 (Buy) rating. The company shows positive earnings momentum with current quarter EPS expected at $0.19 (+18.8% YoY) and fiscal year EPS of $0.79 (+9.7% YoY). Revenue growth is projected at 11.3% for the current fiscal year. The stock has underperformed the S&P 500 over the past month (-2% vs +2.4%) but trades at fair valuation relative to peers.

UiPath (PATH) closed at $13.25, up 1.38%, outperforming the S&P 500's 0.47% decline. The enterprise automation software company is expected to report earnings of $0.19 per share with 18.75% year-over-year growth. With a Zacks Rank of #2 (Buy), a Forward P/E of 16.48 (below industry average of 20.39), and a PEG ratio of 0.76, UiPath appears undervalued. Consensus estimates forecast full-year earnings of $0.79 per share and revenue of $1.79 billion, representing 9.72% and 11.25% growth respectively.

UiPath and Zeta Global are compared as enterprise AI software companies with different growth trajectories. While Zeta Global projects stronger growth (39.4% sales, 34.3% EPS), UiPath is favored as the better buy due to its expanding agentic AI capabilities, workflow orchestration platform, and more attractive valuation at 16.13X forward P/E versus Zeta's 24.68X. UiPath holds a Zacks Rank #2 (Buy) while Zeta Global has Rank #3 (Hold).

UiPath (PATH) stock has declined 7% over the past week but formed a hammer chart pattern suggesting potential trend reversal. The technical signal is supported by fundamental strength, including a 24.1% increase in consensus EPS estimates over the last 30 days and a Zacks Rank #2 (Buy) rating, indicating analyst optimism about the enterprise automation software developer's future earnings.

CrowdStrike demonstrates stronger revenue performance with consistent quarter-over-quarter growth, reaching $1.5 billion in Q2 2026, while UiPath shows more volatile revenue patterns with concerning growth deceleration from 13% to an estimated 8% year-over-year growth in Q3 2026. Both companies benefit from the AI boom, but CrowdStrike's cybersecurity solutions addressing AI-driven threats provide a stronger tailwind compared to UiPath's automation software.

UiPath (PATH) has been heavily searched by investors recently. The stock declined 34.7% over the past month, significantly underperforming the S&P 500's +1% gain. However, earnings estimates have been revised upward substantially, with current fiscal year estimates up 24.1% over the last 30 days. The company maintains a Zacks Rank #2 (Buy) rating, suggesting potential near-term outperformance. UiPath is valued at par with peers and has a history of beating revenue estimates.

The global AI Automation Market is projected to grow from USD 131.19 billion in 2025 to USD 2,041.82 billion by 2035, with a CAGR of 31.62%. North America leads with 32.70% market share, while Asia Pacific shows the fastest growth at 33.07% CAGR. Cloud deployment dominates with 71% share, and intelligent process automation leads automation types. Large enterprises currently control 67% of the market, though SMEs are growing fastest. Key drivers include enterprise AI adoption, generative AI integration, and cloud-based solutions.

UiPath's Chief Product and Technology Officer Raghavendra Malpani sold 40,464 shares worth approximately $567,000 on September 17, 2026, under a pre-established Rule 10b5-1 trading plan. Despite the sale, Malpani maintains a substantial direct holding of 1.6 million shares. The transaction is viewed as non-concerning for investors given the executive's continued significant equity stake and UiPath's strong Q2 financial performance with 13% year-over-year revenue growth.

UiPath's million-dollar customer base grew 21% to 387 customers, significantly outpacing the 10% growth in its broader $100,000+ ARR customer segment. This indicates deeper enterprise penetration and stronger adoption of automation solutions. However, UiPath faces intensifying competition from Pegasystems and ServiceNow as enterprise demand for AI and workflow automation expands.